{"id":124102,"date":"2025-06-24T14:29:10","date_gmt":"2025-06-24T22:29:10","guid":{"rendered":"https:\/\/xira.com\/p\/2025\/06\/24\/janssen-biotech-ordered-to-turn-over-privileged-info-shared-with-consultants-judge-rules\/"},"modified":"2025-06-24T14:29:10","modified_gmt":"2025-06-24T22:29:10","slug":"janssen-biotech-ordered-to-turn-over-privileged-info-shared-with-consultants-judge-rules","status":"publish","type":"post","link":"https:\/\/xira.com\/p\/2025\/06\/24\/janssen-biotech-ordered-to-turn-over-privileged-info-shared-with-consultants-judge-rules\/","title":{"rendered":"Janssen Biotech Ordered to Turn Over Privileged Info Shared With Consultants, Judge Rules"},"content":{"rendered":"

U.S. District Chief Judge F. Dennis Saylor IV of the District of Massachusetts ordered Janssen Biotech, a wholly owned subsidiary of Johnson & Johnson, which manufactures and sells Remicade and Simponi ARIA, to produce related to the litigation, where it is accused of unlawfully providing free services to physicians who prescribed its medications.<\/p>\n

\"\"<\/p>\n

\"\"<\/a>\u00a0\"\"<\/a>\u00a0\"\"<\/a>\u00a0\"\"<\/a>\u00a0\"\"<\/a>\u00a0\"\"<\/a>\u00a0\u00a0<\/div>\n

U.S. District Chief Judge F. Dennis Saylor IV of the District of Massachusetts ordered Janssen Biotech, a wholly owned subsidiary of Johnson & Johnson, which manufactures and sells Remicade and Simponi ARIA, to produce related to the litigation, where it is accused of unlawfully providing free services to physicians who prescribed its medications.<\/p>\n

\"\"<\/p>\n

\"\"<\/a>\u00a0\"\"<\/a>\u00a0\"\"<\/a>\u00a0\"\"<\/a>\u00a0\"\"<\/a>\u00a0\"\"<\/a>\u00a0\u00a0<\/div>\n","protected":false},"excerpt":{"rendered":"

U.S. District Chief Judge F. Dennis Saylor IV of the District of Massachusetts ordered Janssen Biotech, a wholly owned subsidiary of Johnson & Johnson, which manufactures and sells Remicade and Simponi ARIA, to produce related to the litigation, where it is accused of unlawfully providing free services to physicians who prescribed its medications. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 U.S. […]<\/p>\n","protected":false},"author":3,"featured_media":124103,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[23],"tags":[],"class_list":["post-124102","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-com"],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/xira.com\/p\/wp-content\/uploads\/2025\/06\/legal-news-blJzUk.jpeg?fit=767%2C633&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts\/124102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/comments?post=124102"}],"version-history":[{"count":0,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts\/124102\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/media\/124103"}],"wp:attachment":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/media?parent=124102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/categories?post=124102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/tags?post=124102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}